子類別 會議論文/會議摘要 [1/1] 期刊論文 [22/22] 鄰近社群 余佳益 [17/17] 余冠儀 [40/40] 冷治湘 [61/89] 劉士任 [121/149] 劉家齊 [45/52] 司徒惠康 [71/72] 吳綺容 [84/84] 周彥宏 [46/58] 宋旺洲 [33/34] 廖經倫 [32/32] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [60/64] 杜鴻運 [50/50] 楊采菱 [133/134] 潘建雄 [18/19] 羅秀容 [96/97] 莊再成 [104/153] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/195] 許修誌(2005-2010) [1/1] 許素菁 [27/30] 謝鐸源(2006-2014) [20/27] 郭書辰 [139/141] 陳俊宏 [61/62] 陳信偉 [83/110] 陳宜君 [38/38] 陳逢叡 [40/40] 黃明熙 [51/64] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [177/177] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] 社群統計 近3年內發表的文件:3(13.04%) 含全文筆數:23(100.00%) 文件下載次數統計 下載大於0次:23(100.00%) 下載大於100次:22(95.65%) 檔案下載總次數:13514(0.25%) 最後更新時間: 2024-11-28 15:41 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 MDCK-adaptive mutation of A169S cha... Subunit vaccines with a saponin-bas... Characterization and immunogenicity... Development and evaluation of vero ... Development of high-growth influenz... Development and characterization of... Process development for pandemic in... Evaluation of novel disposable bior... Development of american-lineage inf... The stability and immunogenicity of...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-23 / 23. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2024-03-11	MDCK-adaptive mutation of A169S changes glycosylation pattern of hemagglutinin and rnhances MDCK-based H7N9 vaccine virus production without loss of antigenicity and immunogenicity	Vaccines. 2024 Mar 11;12(3):Article number 291.
2023-04-10	Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus	Vaccine. 2023 Apr 10;41(21):3337-3346.
2022-08-29	Characterization and immunogenicity of influenza H7N9 vaccine antigens produced using a serum-free suspension MDCK cell-based platform	Viruses. 2022 Aug 29;14(9):Article number 1937.
2020-10-25	Development and evaluation of vero cell-derived master donor viruses for influenza pandemic preparedness	Vaccines. 2020 Oct 25;8(4):Article number 626.
2020-09-01	Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products	Human Vaccines and Immunotherapeutics. 2020 Sep 1;16(9):2245-2251.
2020-04-02	Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells	Journal of Biomedical Science. 2020 Apr 2;27:Article number 47.
2019-11	The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses	Vaccine. 2019 Nov;37(47):7117-7122.
2019-10	Process development for pandemic influenza VLP vaccine production using a baculovirus expression system	Journal of Biological Engineering. 2019 Oct;13:Article number 78.
2019-08-12	Evaluation of novel disposable bioreactors on pandemic influenza virus production	PLoS ONE. 2019 Aug 12;14(8):Article number 0220803.
2019-06-11	Development of american-lineage influenza H5N2 reassortant vaccine viruses for pandemic preparedness	Viruses. 2019 Jun 11;11(6):Article number 543.
2019-01	Application of stable isotope dimethyl labeling for MRM based absolute antigen quantification of influenza vaccine	Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2019 Jan;1104:40-48.
2018-05	A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography	Vaccine. 2018 May;36(2):3146-3152.
2018-05	Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture	Vaccine. 2018 May;36(22):3134-3139.
2015-03-23	Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets	PLoS ONE. 2015 Mar 23;10(3):Article number e0120793.
2013-11	Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV	Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385.
2012-04	Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates	PLoS ONE. 2012 Apr;7(4):Article number e34834.
2012-03	A cell-based backup to speed up pandemic influenza vaccine production	Trends in Microbiology. 2012 Mar;20(3):103-105.
2011-10	Adaptation of high-growth influenza H5N1 vaccine virus in vero cells: Implications for pandemic preparedness	PLoS ONE. 2011 OCT;6(10):Article number e24057.
2011-01	Production of inactivated influenza H5N1 vaccines from MDCK Cells in serum-free medium	PLoS ONE. 2011 Jan;6(1): Article number e14578.
2010-08	Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice	PLoS ONE. 2010 Aug;5(8):Article number e12279.
2008-12	Adaptation of influenza H5N1 vaccine viruses in vero cells	International Journal of Infectious Diseases. 2008 Dec;12(Suppl. 1):E253-E254.
2008-10	Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines	Vaccine. 2008 Oct;26(45):5736-5740.
2006-12	Characterization of dissolved compounds in submerged anaerobic membrane bioreactors (SAMBRs)	Journal of Chemical Technology and Biotechnology. 2006 Dec;81(12):1894-1904.

顯示項目1-23 / 23. (共1頁) 1  每頁顯示[10|25|50]項目